Actively Recruiting
Inflammation, Diabetes, Ethnicity and Obesity Cohort
Led by University of California, San Francisco · Updated on 2025-07-04
350
Participants Needed
1
Research Sites
617 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Obesity affects over one third of US adults (\>72 million, with BMI ≥30 kg/m2), and the proportion of US adults with BMI ≥40 kg/m2 has doubled in the last 20 years. Obesity is associated with increased mortality through its linkage to comorbidities including diabetes, hypertension, dyslipidemia, osteoarthritis, sleep apnea and psychosocial disturbances. Given its prevalence, impact on morbidity and mortality, and economic cost, limiting the spread of obesity and its consequences is one of the most important problems of our time. In this proposed study, investigators will recruit participants from a wide range of body mass index (BMI), ethnicity and Diabetes risk to collect data and blood, stool and adipose tissue samples in the San Francisco bay area.
CONDITIONS
Official Title
Inflammation, Diabetes, Ethnicity and Obesity Cohort
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants aged 18 to 75 years
- Healthy individuals with stable weight
- Patients with type 2 diabetes or metabolic syndrome
- Individuals scheduled for bariatric or other abdominal surgery at UCSF
You will not qualify if you...
- Chronic kidney disease greater than stage 4
- Autoimmune or inflammatory diseases such as Lupus or Ulcerative Colitis
- Unstable angina or recent severe heart failure or heart attack within 3 months
- Clinically significant liver disease like cirrhosis or liver failure
- Weight over 450 pounds (due to DXA scan limits)
- History of organ transplant
- Currently receiving chemotherapy or radiation therapy
- Poorly controlled asthma requiring steroids
- Use of nasal corticosteroids within the past month
- Excessive alcohol or substance abuse
- Current use of anabolic steroids or testosterone for bodybuilding (testosterone allowed if prescribed for hypogonadism and stable for 6 months)
- Enrollment in other interventional trials with investigational agents
- Pregnant or breastfeeding women
- Unable or unlikely to participate in study procedures
- History of abnormal blood clotting
- Previous bariatric surgery
- Use of anticoagulants
- Use of methadone medication
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California San Francisco
San Francisco, California, United States, 94143
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here